Audible Premium Plus. $0.99/mo for the first 3 months + $20 Audible credits. 12 days only. Get this deal. Cancel anytime.

38 - Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma
Sep 19 2024
Length: 41 mins
Podcast

Failed to add items

Sorry, we are unable to add the item because your shopping cart is already at capacity.

Add to Cart failed.

Please try again later

Add to Wish List failed.

Please try again later

Remove from wishlist failed.

Please try again later

Adding to library failed

Please try again

Follow podcast failed

Please try again

Unfollow podcast failed

Please try again

38 - Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma

Listen for free

View show details

Summary
Discussão do artigo: "Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma" de Hungria V NEJM 2024

Apresentado por: Dr. Matheus Puls

Discussão por: Dr. Lucas Salviano, Dr. Breno Aires, Dra. Aline Guerra, Dr. Pedro Arruda e Dr. Vinicius Molla

Show more Show less

Show more Show less

What listeners say about 38 - Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews

No Reviews are Available

Report a review on Amazon